venBio Global Strategic Fund II L.P. 13D and 13G filings for MENLO THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-04-16 12:47 pm Sale | 2020-04-07 | 13D | MENLO THERAPEUTICS INC MNLO | venBio Global Strategic Fund II L.P. | 0 0.000% | -1,461,552 (Position Closed) | Filing |